These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 4398890)

  • 1. Immunological paralysis of mice with pneumococcal polysaccharide antigens.
    Halliday WJ
    Bacteriol Rev; 1971 Sep; 35(3):267-89. PubMed ID: 4398890
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulation of the antibody response to type 3 pneumococcal polysaccharide. IV. Role of suppressor T cells in the development of low-dose paralysis.
    Baker PJ; Stashak PW; Amsbaugh DF; Prescott B
    J Immunol; 1974 Jun; 112(6):2020-7. PubMed ID: 4151107
    [No Abstract]   [Full Text] [Related]  

  • 3. Conversion of type III pneumococcal polysaccharide low responders to high responders by immunization with a thymus-dependent form of antigen.
    Braley-Mullen H; Sharp GC
    Cell Immunol; 1974 Apr; 12(1):49-60. PubMed ID: 4156496
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. I. Dose-response studies and the effect of prior immunization on the magnitude of the antibody response.
    Baker PJ; Stashak PW; Amsbaugh DF; Prescott B
    Immunology; 1971 Apr; 20(4):469-80. PubMed ID: 4396488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of antilymphocytic antibody on the humoral immune response in different strains of mice. 3. The response to type 3 pneumococcus polysaccharide.
    Ghaffar A; James K
    Immunology; 1973 Jun; 24(6):1075-85. PubMed ID: 4146227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. II. Studies on the relative rate of antibody synthesis and release by antibody-producing cells.
    Baker PJ; Stashak PW; Amsbaugh DF; Prescott B
    Immunology; 1971 Apr; 20(4):481-92. PubMed ID: 4396489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treadmill neutralization of antibody and central inhibition. Separate components of pneumococcal polysaccharide paralysis.
    Howard JG; Christie GH; Courtenay BM
    Transplantation; 1970 Oct; 10(4):251-3. PubMed ID: 4396243
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-pneumococcal polysaccharide type 3 hemolytic plaques in mice: cellular response in immunity and immunologic paralysis.
    Kerman R; Segre D
    J Immunol; 1970 May; 104(5):1262-6. PubMed ID: 4392712
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on immunological paralysis. XI. A comparison of the tolerogenicity in vitro of levan and type 3 pneumococcal polysaccharide.
    Kotlarski I; Courtenay BM; Howard JG
    Eur J Immunol; 1973 Aug; 3(8):496-502. PubMed ID: 4148233
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of antilymphocytic antibody on the humoral immune response of different strains of mice. IV. Variable effect of individual ALG preparations on the immune response to type 3 polysaccharide antigen.
    Ghaffar A; James K
    Immunology; 1974 Jan; 26(1):11-22. PubMed ID: 4152331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter: The basis for conflicting results obtained in studies on the plaque-forming cell response to type III pneumococcal polysaccharide.
    Baker PJ; Prescott B
    J Immunol; 1975 Sep; 115(3):891-2. PubMed ID: 239066
    [No Abstract]   [Full Text] [Related]  

  • 12. Regulation of the antibody response to type 3 pneumococcal polysaccharide. 3. Role of regulatory T cells in the development of an IgG and IgA antibody response.
    Barthold DR; Prescott B; Stashak PW; Amsbaugh DF; Baker PJ
    J Immunol; 1974 Mar; 112(3):1042-50. PubMed ID: 4149561
    [No Abstract]   [Full Text] [Related]  

  • 13. Evidence for the existence of two functionally distinct types of cells which regulate the antibody response to type 3 pneumococcal polysaccharide.
    Baker PJ; Stashak PW; Amsbaugh DF; Prescott B; Barth RF
    J Immunol; 1970 Dec; 105(6):1581-3. PubMed ID: 4394909
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on immunological paralysis. IX. The immunogenicity and tolerogenicity of levan (polyfructose) in mice.
    Miranda JJ
    Immunology; 1972 Dec; 23(6):829-42. PubMed ID: 4405409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirement for lymphocyte-macrophage interaction in the response of mouse spleen cultures to pneumococcal polysaccharide.
    Aaskov JG; Halliday WJ
    Cell Immunol; 1971 Aug; 2(4):335-40. PubMed ID: 4399613
    [No Abstract]   [Full Text] [Related]  

  • 16. Enhancement of the antibody response to type 3 pneumococcal polysaccharide in mice treated with antilymphocyte serum.
    Baker PJ; Barth RF; Stashak PW; Amsbaugh DF
    J Immunol; 1970 May; 104(5):1313-5. PubMed ID: 4392713
    [No Abstract]   [Full Text] [Related]  

  • 17. Strain differences in the antibody plaque-forming cell responses of inbred mice to pneumococcal polysaccharide.
    Braley HC; Freeman MJ
    Cell Immunol; 1971 Feb; 2(1):73-81. PubMed ID: 4399154
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased plaque-forming cell response to pneumococcal polysaccharide type 3-coated sheep erythrocytes after priming with erythrocytes but not with polysaccharide.
    Byfield P
    Cell Immunol; 1972 Apr; 3(4):616-22. PubMed ID: 4401911
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on immunological paralysis. VI. Thymic-independence of tolerance and immunity to type 3 pneumococcal polysaccharide.
    Howard JG; Christie GH; Courtenay BM; Leuchars E; Davies AJ
    Cell Immunol; 1971 Dec; 2(6):614-26. PubMed ID: 4149977
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on immunological paralysis. V. The influence of molecular weight on the immunogenicity, tolerogenicity and antibody-neutralizing activity of the 3 pneumococcal polysaccharide.
    Howard JG; Zola H; Christie GH; Courtenay BM
    Immunology; 1971 Sep; 21(3):535-46. PubMed ID: 4398137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.